Nora D. Möhn MD

Dr. Nora Möhn is resident at the Department of Neurology at Hannover Medical School. After a study abroad in St Gallen, Switzerland, she received her medical degree from Hannover Medical School. Her research studies focus on improving the care of patients receiving oncological immunotherapies. The main area of interest is the investigation of neurological adverse events during immune checkpoint inhibitor therapy and CAR T cell therapy. Together with colleagues from Hannover Medical School she founded the Immune Cooperative Oncology Group (ICOG) which is responsible for interdisciplinary care and comprehensive investigation of patients treated with immune checkpoint inhibitors. In addition, she is involved in the implementation of innovative treatment strategies for patients suffering progressive multifocal leukoencephalopathy (PML).